je.st
news
FDA seeks expert input on ideal patient group for experimental cholesterol-lowering drug
2015-06-08 17:44:34| Biotech - Topix.net
Federal health regulators say a highly-anticipated, experimental drug from Amgen significantly lowers bad cholesterol. But officials have questions about who should take the drug and whether to approve it based on currently available data.
Tags: group
drug
ideal
expert
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|